TG Therapeutics TGTX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $79.15M-56.0% | $179.89M+93.6% | $92.93M-9.2% | $102.3M-65.8% | ||
| $1.34M+3.4% | $1.3M+1.0% | $1.29M+0.9% | $1.27M+0.7% | ||
| $992.65M+152% | $393.5M+238% | $116.52M+12,804% | $903K-79.8% | ||
| $475.6M+95.2% | $243.63M+86.2% | $130.83M— | —— | ||
| $57.58M+266% | $15.72M+65.1% | $9.52M+304% | $2.36M-18.2% | ||
| $630.76M+11.4% | $566.36M+78.1% | $317.94M+88.9% | $168.27M-49.2% | ||
| $6.28M-12.2% | $7.15M-11.2% | $8.05M-9.4% | $8.89M+3.0% | ||
| —— | —— | $0— | —— | ||
| $2.04M-1.4% | $2.07M-10.2% | $2.31M— | —— | ||
| $59.14M+7,219% | $808K— | $0-100% | $12.4M-65.1% | ||
| $62.82M-52.1% | $131.11M+5.2% | $124.58M+110% | $59.37M— | ||
| $1.06B+84.1% | $577.69M+75.3% | $329.59M+70.3% | $193.57M-49.0% | ||
| $107.51M+84.4% | $58.3M+51.5% | $38.47M-8.4% | $42.02M-18.1% | ||
| $2.12M-54.1% | $4.63M+213% | $1.48M+26.5% | $1.17M-22.7% | ||
| $21.85M+43.9% | $15.19M+24.8% | $12.17M+44.4% | $8.43M-17.1% | ||
| $8.81M-27.1% | $12.09M+101% | $6.02M+1,872% | $305K-33.3% | ||
| $1.04M-9.8% | $1.16M-20.0% | $1.45M-8.5% | $1.58M+10.0% | ||
| $153.76M+69.6% | $90.68M+68.8% | $53.72M+1.0% | $53.2M-18.6% | ||
| $245.65M+0.5% | $244.43M+144% | $100.12M+40.7% | $71.14M+6.5% | ||
| $7.02M-13.7% | $8.13M-11.9% | $9.23M-10.8% | $10.34M+5.0% | ||
| $8.07M-13.2% | $9.29M-13.0% | $10.68M-10.5% | $11.93M+5.7% | ||
| $415.23M+16.9% | $355.33M+110% | $169.09M+25.3% | $134.99M-5.3% | ||
| $159K+1.9% | $156K+3.3% | $151K-99.9% | $175M+122,278% | ||
| $1.83B+4.0% | $1.76B+2.8% | $1.71B+8.0% | $1.59B+1.3% | ||
| -$1.08B+29.2% | -$1.53B+1.5% | -$1.55B-1.7% | -$1.53B-14.9% | ||
| $100.23M+1,014% | $8.99M+3,744% | $234K0.0% | $234K0.0% | ||
| $648.02M+191% | $222.36M+38.5% | $160.5M+174% | $58.59M-75.3% | ||
| $1.06B+84.1% | $577.69M+75.3% | $329.59M+70.3% | $193.57M-49.0% | ||
| $57.58M+266% | $15.72M+65.1% | $9.52M+304% | $2.36M-18.2% | ||
| $2.04M-1.4% | $2.07M-10.2% | $2.31M— | —— | ||
| $6.28M-12.2% | $7.15M-11.2% | $8.05M-9.4% | $8.89M+3.0% | ||
| $348M— | $0— | —— | —— | ||
| $59.14M+7,219% | $808K— | $0-100% | $12.4M-65.1% | ||
| $6.28M-12.2% | $7.15M-11.2% | $8.05M-9.4% | $8.89M+3.0% | ||
| $2.04M-1.4% | $2.07M-10.2% | $2.31M— | —— | ||
| $62.82M-52.1% | $131.11M+5.2% | $124.58M+110% | $59.37M+274% | ||
| $6.28M-12.2% | $7.15M-11.2% | $8.05M-9.4% | $8.89M+3.0% | ||
| $2.04M-1.4% | $2.07M-10.2% | $2.31M— | —— | ||
| $107.51M+84.4% | $58.3M+51.5% | $38.47M-8.4% | $42.02M-18.1% | ||
| $21.23M+86.0% | $11.41M+7,409% | $152K0.0% | $152K— | ||
| $2.12M-54.1% | $4.63M+213% | $1.48M+26.5% | $1.17M-22.7% | ||
| $8.81M-27.1% | $12.09M+101% | $6.02M+1,872% | $305K-33.3% | ||
| $253.71M0.0% | $253.72M+129% | $110.8M+33.4% | $83.06M+5.1% | ||
| $159K+1.9% | $156K+3.3% | $151K+3.4% | $146K+2.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TG Therapeutics's total assets?
- TG Therapeutics (TGTX) holds $1.5B in total assets, up 132.8% year over year.
- How much debt does TG Therapeutics have?
- TG Therapeutics carries $753.6M in total debt against $583.1M of shareholders' equity, a debt-to-equity ratio of 1.29.
- How much cash does TG Therapeutics have?
- TG Therapeutics holds $442.2M in cash and equivalents.
- Can TG Therapeutics cover its short-term obligations?
- Its current ratio is 5.81 — current assets exceed current liabilities.
- Where does TG Therapeutics's balance sheet data come from?
- Every line is extracted from TG Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
